The Biological Fate of 4-Butyl-4-(β-carboxypropionyloxymethyl)-1, 2-diphenyl-3, 5-pyrazolidinedione (Suxibuzone), Antiinflammatory Drug. I. Plasma Levels and Urinary Excretion after Oral Administration of Suxibuzone
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.